NCT06754722 Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
| NCT ID | NCT06754722 |
| Status | Recruiting |
| Phase | — |
| Sponsor | 5 Point App, Inc. |
| Condition | Cancer-related Problem/Condition |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2026-04-01 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to evaluate whether EnergyPoints, a mobile phone health app that guides the participant to do self-acupressure, can decrease fatigue and improve sleep. Acupressure consists of applying physical pressure with fingers or a device to small locations on the body called acupoints. * The investigators will conduct this clinical trial remotely, allowing participants to use the app wherever they are. Participation will involve using the app daily while wearing a fitness tracker (a Fitbit) on the wrist, answering questions on the app and online, as well as completing a questionnaire and participating in an online interview at the end of the study. Participants will be assigned by chance to one of two groups. In both groups, participants will have a 1 week baseline week (Week 0) to get used to the Fitbit. Participants in the Immediate Group will start the 6 week trial of EnergyPoints immediately (Week 1). Participants in the Wait-List Group will be on a wait-list for 6 weeks during which time they will wear the Fitbit and answer online questions daily and weekly. At the end of the waiting period (week 7), these participants will begin the 6 week trial of EnergyPoints. * The risks to participating are minimal. There is a small risk of bruising or getting sore at a point where participants apply pressure. As with any mobile app, there is the possibility that electronic information could be viewed by third parties not involved in the study. The investigators cannot promise any benefits from participating in the study. However, it is possible that using acupressure might improve fatigue or sleep. Participants may use any other approaches to improve fatigue and sleep while in the study. A pilot study will be conducted first with 8 participants and 1 week periods (1 week baseline, 1 week waitlist, and 1 week intervention followed by an End of Study Questionnaire and Exit Interview
Eligibility Criteria
Inclusion Criteria: * Have cancer or have been treated for cancer; * at least a moderate level of fatigue (greater than 4 on a 0 to 10 Likert-type scale); * able to read and speak in English; * age 18 years or older; Android 11 or later), * adequate hearing, vision, and functional ability to see, hear and use the app and participate in interviews, * willing to wear a provided Fitbit 24/7 (except when charging) throughout the study. Exclusion Criteria: * recent history of easy bruising or bleeding * previous use of the EnergyPoints app. Note: The functional ability questions will exclude anyone who is too sick to participate due to life-limiting disease.
Contact & Investigator
Susan L Beck, PhD
PRINCIPAL INVESTIGATOR
5 Point App, Inc.
Frequently Asked Questions
Who can join the NCT06754722 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer-related Problem/Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06754722 currently recruiting?
Yes, NCT06754722 is actively recruiting participants. Contact the research team at susie@5pointapp.com for enrollment information.
Where is the NCT06754722 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06754722 clinical trial?
NCT06754722 is sponsored by 5 Point App, Inc.. The principal investigator is Susan L Beck, PhD at 5 Point App, Inc.. The trial plans to enroll 180 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.